论文部分内容阅读
促性腺激素释放激素拮抗剂(GnRHA)加尼瑞克可以减少早发的黄体生成激素(LH)高峰,在可控制性超排卵(COS)中得到广泛的应用。本研究针对标准剂量(0.25mg)和高剂量(2.0mg)GnRHA与促性腺激素释放激素激动剂(GnRHa)对接受COS治疗的赠卵者的子宫内膜的影响作了比较和评价。方法:42例
Gonadotropin-Releasing Hormone Antagonist (GnRHA) Ganirelix reduces premature LH peak and is widely used in controlled ovarian hyperstimulation (COS). This study compared and evaluated the effects of standard doses (0.25 mg) and high doses (2.0 mg) of GnRHA and gonadotropin-releasing hormone agonist (GnRHa) on the endometrium of COS-treated donors. Methods: 42 cases